Premium
Motivations for methamphetamine cessation among young people in northern Thailand
Author(s) -
German Danielle,
Sherman Susan G.,
Sirirojn Bangorn,
Thomson Nick,
Aramrattana Apinun,
Celentano David D.
Publication year - 2006
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/j.1360-0443.2006.01490.x
Subject(s) - psychological intervention , medicine , grounded theory , population , smoking cessation , peer pressure , psychiatry , clinical psychology , psychology , family medicine , environmental health , qualitative research , social psychology , social science , pathology , sociology
Aim To understand factors influencing cessation intentions among young Thai methamphetamine (MA) users, a population with dramatically increasing rates of MA use. Design and participants A total of 48 in‐depth interviews conducted between March 2002 and January 2003 with current and recent MA users aged 15–29 years. Setting Chiang Mai city and surrounding district, Thailand. Measurement Interviews addressed family history, drug use patterns and influences, cessation history, drug treatment experiences and sexual behavior. Data were analyzed inductively using the constant comparative method common to grounded theory methods. Atlas‐ti was used for data management. Findings Cessation intentions were motivated by a range of internal and external influences, including attitudes towards continued MA use shaped by recognition of negative impact on self and others; influence of family, peers, partners and community stigma; perceptions on cessation and drug treatment; and external facilitators and situational barriers, such as extensive peer pressure and drug availability. In most cases, multiple factors operated simultaneously. Some variation according to duration of use and treatment status was observed. Conclusions Evidence‐based interventions addressing MA use among Thai young people are urgently needed. These data support the continuation of evidence‐based drug treatment at levels adequate to address the population need and implementation a multi‐faceted approach that aims to enhance identified cessation influences in this population and minimize contextual barriers to cessation.